Xtx Topco LTD Lantheus Holdings, Inc. Transaction History

Xtx Topco LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$58.87 - $83.05 $229,651 - $323,978	3,901 New	3,901 $313,000
Q2 2023 Aug 14, 2023	BUY	$82.41 - $99.65 $524,786 - $634,571	6,368 Added 215.79%	9,319 $782,000
Q1 2023 May 12, 2023	SELL	$47.76 - $82.86 $174,276 - $302,356	-3,649 Reduced 55.29%	2,951 $243,000
Q4 2022 Feb 14, 2023	SELL	$48.76 - $77.67 $158,177 - $251,961	-3,244 Reduced 32.95%	6,600 $336,000
Q3 2022 Nov 14, 2022	BUY	$61.42 - $86.29 $202,317 - $284,239	3,294 Added 50.29%	9,844 $692,000
Q2 2022 Aug 15, 2022	BUY	$55.54 - $72.65 $363,787 - $475,857	6,550 New	6,550 $432,000

540

68M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.14B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.